S‐1 vs 5‐FU‐containing regimens
Time‐to treatment failure · people with advanced gastric cancer
S‐1 showed no clear difference in time‐to treatment failure compared with 5‐FU‐containing regimens (low certainty).
1 finding from 1 review
- HR 0.88 [0.76, 1.01]5 studies · 1818 participantsLow